Thrombosis News and Research

Latest Thrombosis News and Research

SARS-CoV-2 infection can exacerbate production of auto-antibodies relating to auto-immune diseases

An article published in NPJ Aging, a Springer Nature journal, reveals that natural production of auto-antibodies increases with age and that infection by SARS-CoV-2 can exacerbate production of auto-antibodies relating to auto-immune diseases, helping to explain why aging increases the chances of developing severe COVID-19.

12 Sep 2023

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.

9 Sep 2023

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

The National Comprehensive Cancer Network today announced the publication of a new supportive care patient guideline focused on preventing and treating cancer-associated blood clots, also known as venous thromboembolism (VTE).

8 Sep 2023

NSAID use linked to higher risk of blood clots in women of reproductive age, association stronger in women on high-risk hormonal contraception

A new paper published in The BMJ explores the effect of these drugs used concomitantly on the risk of venous thromboembolism (VTE).

8 Sep 2023

Obesity in early pregnancy increases long-term risk of venous thromboembolism

Investigated the association between obesity in early pregnancy and long-term post-pregnancy risk of venous thromboembolism.

7 Sep 2023

Scientists discover new role for liver tPA in regulating cholesterol levels

Despite advances in treatment for high cholesterol, heart disease remains the leading cause of death in the U.S. Scientists at the Medical College of Wisconsin (MCW) are investigating the role of a form of cholesterol called very-low-density lipoprotein – and their findings may lead to new treatment options in the future.

1 Sep 2023

Activist misuses federal data to make false claim that covid vaccines killed 676,000

A blog post shared on Facebook claimed that covid-19 vaccines have killed some 676,000 Americans.

1 Sep 2023

Is drinking water hardness associated with cardiovascular disease mortality?

Total drinking water hardness can protect against cardiovascular disease mortality.

30 Aug 2023

Stunning differences found between men and women in heart disease diagnosis, treatment and symptoms

More than a dozen medical studies from around the globe show women suffer worse outcomes when diagnosed with and treated for cardiac issues – the No. 1 killer in the world according to the Centers for Disease Control.

29 Aug 2023

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischemic events in acute coronary syndrome (ACS) patients at high risk for both types of events.

29 Aug 2023

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Sodium glucose co-transporter-2 (SGLT2) inhibitors do not lead to lower 28-day all-cause mortality compared with usual care or placebo in patients hospitalized with COVID-19, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis (DVT), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Switching vitamin K antagonist (VKA) treatment to a non-vitamin K antagonist oral anticoagulant (NOAC) in frail elderly patients with atrial fibrillation is associated with more bleeding complications compared to continuing VKA treatment.

28 Aug 2023

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for cardiovascular events in patients with acute coronary syndrome (ACS) or high bleeding risk (HBR), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

New DNA-based anticoagulant could treat heparin-induced thrombocytopenia

Various medical circumstances, including heart attacks and extreme cases of COVID-19, necessitate the use of anticoagulants, medicines that prevent blood clots

21 Aug 2023

Adenovirus infection linked to rare blood clotting disorder

Platelets, or thrombocytes, are specialized cellular fragments that form blood clots when we get scrapes and traumatic injuries. Viral infections, autoimmune disease, and other conditions can cause platelet levels to drop throughout the body, termed thrombocytopenia.

10 Aug 2023

Study explores changes in cardiovascular disease hospitalization trends during the COVID-19 pandemic

A group of researchers examined the variations in cardiovascular disease hospitalizations pre- and post-COVID-19 pandemic.

10 Aug 2023

Thrombosis News and Research

Latest Thrombosis News and Research

SARS-CoV-2 infection can exacerbate production of auto-antibodies relating to auto-immune diseases

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

NSAID use linked to higher risk of blood clots in women of reproductive age, association stronger in women on high-risk hormonal contraception

Obesity in early pregnancy increases long-term risk of venous thromboembolism

Scientists discover new role for liver tPA in regulating cholesterol levels

Activist misuses federal data to make false claim that covid vaccines killed 676,000

Is drinking water hardness associated with cardiovascular disease mortality?

Stunning differences found between men and women in heart disease diagnosis, treatment and symptoms

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

New DNA-based anticoagulant could treat heparin-induced thrombocytopenia

Adenovirus infection linked to rare blood clotting disorder

Study explores changes in cardiovascular disease hospitalization trends during the COVID-19 pandemic

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Thrombosis News and Research

Latest Thrombosis News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in